With the recent changes in the Beers Criteria, glimepiride has now been added to the list of sulfonylureas to avoid. Glipizide is the preferred agent if a sulfonylurea is to be used. This begs the question, should we recommend changing glimepiride to glipizide? In my...
Metformin is the go-to first-line medication in type 2 diabetes. While drug interactions aren’t incredibly common with its use, we should be aware of OCT inhibition and the potential effects that this might cause. Under normal circumstances, this isn’t...
The author has no conflicts of interest regarding oral semaglutide or any other diabetes medication. The GLP-1 agonists have been growing in popularity. The benefit of good A1C lowering effect coupled with the potential for weight loss are two of the main reasons why...
Glucagon can be a lifesaver, literally. Glucagon’s primary use is in the setting of severe hypoglycemia. Glucagon works by increasing cyclic AMP which causes glycogenolysis and gluconeogenesis. This ultimately leads to an increase in glucose in the blood and helps...
Orthostasis risk with SGLT-2 Inhibitors is a potential minor concern, particularly in our geriatric population. While a drop in blood pressure can be a good thing for a significant chunk of diabetes patients, that potential modest drop can lead to an increased...
Today I’m going to discuss a case involving a patient concern with inappropriate production of milk (formally known as galactorrhea). Keep an eye at the end of this post for some MAJOR announcements about upcoming content releases! For now, here’s the...
